MedTrace Logo

DeNovo NT Ankle LDC Study

NCT01347892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this post-market clinical study is to collect long-term outcomes for DeNovo NT Graft treatment of articular cartilage lesions in the ankle in a standard clinical setting. Outcomes to be assessed include pain, function, activity levels and healthcare resource use.

Conditions

  • Defect of Articular Cartilage
  • Osteochondral Lesion of Talus
  • Osteochondritis Dissecans

Interventions

OTHER

DeNovo NT Natural Tissue Graft

DeNovo NT is a juvenile cartilagenous tissue graft, inclusive of a viable human cartilage cells. It is provided as particulated tissue pieces of approximately 1mm3 each

Sponsors & Collaborators

  • Zimmer Orthobiologics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2019-07-31
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01347892 on ClinicalTrials.gov